Show
Sort by
-
Ocular graft-versus-host disease in allogeneic stem cell transplant recipients : a longitudinal cohort study evaluating ocular surface parameters before and after transplantation
-
Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B-8800 in lower-risk myelodysplastic syndrome
-
Primary analysis of the randomized, phase 3 VERONA study of venetoclax with azacitidine versus placebo with azacitidine in patients with treatment-naïve, intermediate and higher-risk myelodysplastic syndromes
(2025) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. In Clinical Lymphoma Myeloma & Leukemia 25(Supplement 1). p.S644-S645 -
Toward clinical implementation of a volumetric absorptive microsampling-based method for dasatinib and imatinib therapeutic drug monitoring
-
Subgroup analyses from the randomized, Phase 3 VERONA study of venetoclax with azacitidine (Ven plus Aza) versus placebo with azacitidine (Pbo plus Aza) in patients with treatment-naïve, intermediate and higher-risk Myelodysplastic Syndromes (HR MDS)
-
- Journal Article
- A1
- open access
Treatment of chronic myeloid leukemia chronic phase patients in third-line setting and beyond : recommendations from a Belgian expert panel in 2025
-
- Journal Article
- A1
- open access
Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib : final 6-year results from a Belgian registry
-
- Journal Article
- A1
- open access
Disease perception is correlated with health-related quality of life in patients suffering from myelodysplastic syndromes : results of the Belgian Be-QUALMS study
-
- Conference Paper
- C3
- open access
Systemic mastocytosis with myeloid sarcoma and B-CLL : molecular and clonal heterogeneity in a rare case of SM-AHN
-
- Journal Article
- A1
- open access
Immune complex glomerulonephritis in a patient with myelodysplastic syndrome with ring sideroblasts treated with luspatercept